Ventilator-associated pneumonia in neonatal and pediatric intensive care unit patients

Clinical Microbiology Reviews

Volumn 20, Issue 3, 2007, Pages 409-425

  Foglia, Elizabeth ^a   Meier, Mary Dawn ^a   Elward, Alexis ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST LOUIS CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPHOTERICIN B; CARBAPENEM DERIVATIVE; CEFEPIME; CEPHALOSPORIN DERIVATIVE; CHLORHEXIDINE; CIPROFLOXACIN; COLISTIN; GENTAMICIN; HISTAMINE H2 RECEPTOR ANTAGONIST; IMIPENEM; LINEZOLID; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; NYSTATIN; OMEPRAZOLE; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RANITIDINE; STEROID; SUCRALFATE; TOBRAMYCIN; VANCOMYCIN;

ARTIFICIAL VENTILATION; BACTERIUM ISOLATION; CLINICAL TRIAL; COLIFORM BACTERIUM; DIAGNOSTIC PROCEDURE; GOLD STANDARD; HAEMOPHILUS INFLUENZAE; HIGH RISK PATIENT; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; LENGTH OF STAY; LUNG LAVAGE; META ANALYSIS; MONOTHERAPY; MORBIDITY; NEPHROTOXICITY; NEWBORN INTENSIVE CARE; NONHUMAN; OTOTOXICITY; PSEUDOMONAS AERUGINOSA; REVIEW; RISK FACTOR; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS PNEUMONIAE; SYMPTOMATOLOGY; SYSTEMATIC REVIEW; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; VENTILATOR ASSOCIATED PNEUMONIA;

ADOLESCENT; ANTI-INFECTIVE AGENTS; CHILD; CHILD, PRESCHOOL; CLINICAL TRIALS; CROSS INFECTION; DISEASE ATTRIBUTES; HISTAMINE H2 ANTAGONISTS; HUMANS; HYGIENE; INFANT; INTENSIVE CARE UNITS; INTENSIVE CARE UNITS, PEDIATRIC; PNEUMONIA, VENTILATOR-ASSOCIATED; POPULATION SURVEILLANCE; RESPIRATION, ARTIFICIAL; RISK FACTORS; SENTINEL SURVEILLANCE; SUCRALFATE; UNITED STATES;

EID: 34547396873     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/CMR.00041-06     Document Type: Review

References (101)

1. Almuneef, M., Z. A. Memish, H. H. Balkhy, H. Alalem, and A. Abutaleb. 2004. Ventilator-associated pneumonia in a pediatric intensive care unit in Saudi Arabia: a 30-month prospective surveillance. Infect. Control Hosp. Epidemiol. 25:753-758.
2. American Thoracic Society. 2005. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am. J. Respir. Crit. Care Med. 171:388-416.
3. Apisarnthanarak, A., G. Holzmann-Pazgal, A. Hamvas, M. A. Olsen, and V. J. Fraser. 2003. Ventilator-associated pneumonia in extremely preterm neonates in a neonatal intensive care unit: characteristics, risk factors, and outcomes. Pediatrics 112:1283-1289.
4. Babcock, H. M., J. E. Zack, T. Garrison, E. Trovillion, M. Jones, V. J. Fraser, and M. H. Kollef. 2004. An educational intervention to reduce ventilator-associated pneumonia in an integrated health system: a comparison of effects. Chest 125:2224-2231.
5. Babcock, H. M., J. E. Zack, T. Garrison, E. Trovollion, M. H. Kollef, and V. J. Fraser. 2003. Ventilator-associated pneumonia in a multi-hospital system: differences in microbiology by location. Infect. Control Hosp. Epidemiol. 24:853-858.
6. Baltimore, R. S. 1998. Neonatal nosocomial infections. Semin. Perinatol. 22:25-32.
7. Barret, J. P., M. G. Jeschke, and D. N. Herndon. 2001. Selective decontamination of the digestive tract in severely burned pediatric patients. Burns 27:439-445.
8. Bercault, N., and T. Boulain. 2001. Mortality rate attributable to ventilator-associated nosocomial pneumonia in an adult intensive care unit: a prospective case-control study. Crit. Care Med. 29:2303-2309.
9. Bergmans, D. C., M. J. Bonten, C. A. Gaillard, J. C. Paling, S. van der Geest, F. H. van Tiel, A. J. Beysens, P. W. de Leeuw, and E. E. Stobberingh. 2001. Prevention of ventilator-associated pneumonia by oral decontamination: a prospective, randomized, double-blind, placebo-controlled study. Am. J. Respir. Crit. Care Med. 164:382-388.
10. Black, S. R., E. Lo, M. Madriaga, M. Zimmerman, and J. Segreti. 2002. Nosocomial pneumonia in the PICU. Abstr. 40th Intersci. Conf. Antimicrob. Agents Chermother., abstr. K-452.
11. Brook, I. 1996. Treatment of aspiration or tracheostomy-associated pneumonia in neurologically impaired children: effect of antimicrobials effective against anaerobic bacteria. Int. J. Pediatr. Otorhinolaryngol. 35:171-177.
12. Burmester, M., and Q. Mok. 2001. How safe is non-bronchoseopic bronchoalveolar lavage in critically ill mechanically ventilated children? Intensive Care Med. 27:716-721.
13. Chastre, J., F. Viau, P. Brun, J. Pierre, M. C. Dauge, A. Bouchama, A. Akesbi, and C. Gibert. 1984. Prospective evaluation of the protected specimen brush for the diagnosis of pulmonary infections in ventilated patients. Am. Rev. Respir. Dis. 130:924-929.
14. Chastre, J., M. Wolff, J. Y. Fagon, S. Chevret, F. Thomas, D. Wermert, E. Clementi, J. Gonzalez, D. Jusserand, P. Asfar, D. Perrin, F. Fieux, S. Aubas, and the PneumA Trial Group. 2003. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA 290:2588-2598.
15. Chlebicki, M. P., and N. Safdar. 2007. Topical chlorhexidine for prevention of ventilator-associated pneumonia: a meta-analysis. Crit. Care Med. 35:595-602.
16. Collard, H. R., S. Saint, and M. A. Matthay. 2003. Prevention of ventilator-associated pneumonia: an evidence-based systematic review. Ann. Intern. Med. 138:494-501.
17. Combes, P., B. Fauvage, and C. Oleyer. 2000. Nosocomial pneumonia in mechanically ventilated patients, a prospective randomized evaluation of the Sterieath closed suctioning system. Intensive Care Med. 26:878-882.
18. Cook, D. J., B. K. Reeve, G. H. Guyatt, D. K. Heyland, L. E. Griffith, L. Buckingham, and M. Tryba. 1996. Stress ulcer prophylaxis in critically ill patients. Resolving discordant meta-analyses. JAMA 275:308-314.
19. Cordero, L., L. W. Ayers, R. R. Miller, J. H. Seguin, and B. D. Coley. 2002. Surveillance of ventilator-associated pneumonia in very-low-birth-weight infants. Am. J. Infect. Control 30:32-39.
20. Cordero, L., M. Sananes, and L. W. Ayers. 2000. Comparison of a closed (Trach Care MAC) with an open endotracheal suction system in small premature infants. J. Perinatol. 3:151-156.
21. Curley, M. A., E. Schwalenstocker, J. K. Deshpande, C. C. Ganser, D. Bertoch, J. Brandon, and P. Kurtin. 2006. Tailoring the Institute for Health Care Improvement 100,000 Lives Campaign to pediatric settings: the example of ventilator-associated pneumonia. Pediatr. Clin. N. Am. 53:1231-1251.
22. Department of Health and Human Services. 23 August 2006, accession date. Criteria for defining nosocomial pneumonia. http://www.cdc.gov/ncidod/ hip/NNIS/members/pneumonia/Final/PneumoCriteriaV1.pdf.
23. Deppe, S. A., J. W. Kelly, L. L. Thoi, J. H. Chudy, R. N. Longfield, J. P. Ducey, C. L. Truwit, and M. R. Antopol. 1990. Incidence of colonization, nosocomial pneumonia, and mortality in critically ill patients using a Trach Care closed-suction system versus an open-suction system: prospective, randomized study. Crit. Care Med. 18:1389-1393.
24. Donowitz, L. G. 1989. Nosocomial infection in neonatal intensive care units. Am. J. Infect. Control 17:250-257.
25. Drakulovic, M. B., A. Torres, T. T. Bauer, J. M. Nicolas, S. Nogué, and M. Ferrer. 1999. Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomised trial. Lancet 354:1851-1858.
26. Drews, M. B., A. C. Ludwig, J. U. Leititis, and F. D. Daschner. 1995. Low birth weight and nosocomial infection of neonates in a neonatal intensive care unit. J. Hosp. Infect. 30:65-72.
27. Durand, M., B. Sangha, L. A. Cabal, T. Hoppenbrouwers, and J. E. Hodgman. 1989. Cardiopulmonary and intracranial pressure changes related to endotracheal suctioning in preterm infants. Crit. Care Med. 17:506-510.
28. Elward, A. M., D. K. Warren, and V. J. Fraser. 2002. Ventilator-associated pneumonia in pediatric intensive care unit patients: risk factors and outcomes. Pediatrics 109:758-764.
29. Ely, E. W., A. M. Baker, D. P. Dunagan, H. L. Burke, A. C. Smith, P. T. Kelly, M. M. Johnson, R. W. Browder, D. L. Bowton, and E. F. Haponik. 1996. Effect on the duration of mechanical ventilation of identifying patients capable of breathing spontaneously. N. Engl. J. Med. 335:1864-1869.
30. Fabregas, N., S. Ewig, A. Torres, M. El-Ebiary, J. Ramirez, J. P. de La Bellacasa, T. Bauer, and H. Cabello. 1999. Clinical diagnosis of ventilator associated pneumonia revisited: comparative validation using immediate post-mortem lung biopsies. Thorax 54:867-873.
31. Fagon, J. Y., J. Chastre, A. J. Hance, P. Montravers, A. Novara, and C. Gibert. 1993. Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am. J. Med. 94:281-288.
32. Fayon, M. J., M. Tucci, J. Lacroix, C. A. Farrell, M. Gauthier, L. Lafteur, and D. Nadeau. 1997. Nosocomial pneumonia and tracheitis in a pediatric intensive care unit: a prospective study. Am. J. Respir. Crit. Care Med. 155:162-169.
33. Fischer, J. E., M. Ramser, and S. Fanconi. 2000. Use of antibiotics in pediatric intensive care and potential savings. Intensive Care Med. 26:959-966.
34. Fischer, J. E., P. Allen, and S. Fanconi. 2000. Delay of extubation in neonates and children after cardiac surgery: impact of ventilator-associated pneumonia. Intensive Care Med. 26:942-949.
35. Fitch, J. A., C. L. Munro, C. A. Glass, and J. M. Pellegrini. 1999. Oral care in the adult intensive care unit. Am. J. Crit. Care 8:314-318.
36. Flanagan, P. G. 1999. Diagnosis of ventilator-associated pneumonia. J. Hosp. Infect. 41:87-99.
37. Flanagan, P. G., G. P. Findlay, J. T. Magee, A. Ionescu, R. A. Barnes, and M. Smithies. 2000. The diagnosis of ventilator-associated pneumonia using non-bronchoscopic, non-directed lung lavages. Intensive Care Med. 26:20-30.
38. Foglia, E., C. Hollenbeak, V. Fraser, and A. Elward. 2006. Costs associated with nosocomial bloodstream infections and ventilator-associated pneumonia in pediatric intensive care unit patients. Abstr. 16th Annu. Meet. Soc. Healthcare Epidemiol. America, abstr. 109.
39. Ford-Jones, E. L., C. M. Mindorff, J. M. Langley, U. Allen, L. Navas, M. L. Patrick, R. Milner, and R. Gold. 1989. Epidemiologic study of 4684 hospital-acquired infections in pediatric patients. Pediatr. Infect. Dis. J. 8:668-675.
40. Forman, M. L., and E. R. Stiehm. 1969. Impaired opsonic activity but normal phagocytosis in low-birth-weight infants. N. Engl. J. Med. 281:926-931.
41. Garner, J. S., W. R. Jarvis, T. G. Emori, T. C. Horan, and J. M. Hughes. 1996. CDC definitions for nosocomial infections, p. A1-A19. In R. N. Olmsted (ed.), APIC infection control and applied epidemiology: principles and practice. Mosby, St. Louis, MO.
42. Gauvin, F., C. Dassa, M. Chaibou, F. Proulx, C. A. Farrell, and J. Lacroix. 2003. Ventilator-associated pneumonia in intubated children: comparison of different diagnostic methods. Pediatr. Crit. Care Med. 4:437-443.
43. Gaynes, R. P., J. R. Edwards, W. R. Jarvis, D. H. Culver, J. S. Tolson, W. J. Martone, and the National Nosocomial Infection Surveillance System. 1996. Nosocomial infections among neonates in high-risk nurseries in the United States. Pediatrics 98:357-361.
44. Goldmann, D. A., J. Freeman, and W. A. Durbin, Jr. 1983. Nosocomial infection and death in a neonatal intensive care unit. J. Infect. Dis. 147: 635-641.
45. Gordon, A., and D. Isaacs. 2004. Late-onset infection and the role of antibiotic prescribing policies. Curr. Opin. Infect. Dis. 17:231-236.
46. Haas, J. P., E. A. Mendonca, B. Ross, C. Friedman, and E. Larson. 2005. Use of computerized surveillance to detect nosocomial pneumonia in neonatal intensive care unit patents. Am. J. Infect. Control 33:439-443.
47. Harpin, V. A., and N. Rutter. 1983. Barrier properties of the newborn infant's skin. J. Pediatr. 102:419-425.
48. Hemming, V. G., J. C. Overall, Jr., and M. R. Britt. 1976. Nosocomial infections in a newborn intensive-care unit. Results of forty-one months of surveillance. N. Engl. J. Med. 294:1310-1316.
49. Herruzo-Cabrera, R., J. I. Garcia Gonzalez, P. Garcia-Magan, and J. del Rey-Calero. 1994. Nosocomial infection in a neonatal intensive care unit and its prevention with selective intestinal decolonization: a multivariant evaluation of infection reduction. Eur. J. Epidemiol. 10:573-580.
50. Heyland, D. K., D. J. Cook, L. Griffith, S. P. Keenan, C. Brun-Buisson, et al. 1999. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. Am. J. Respir. Crit. Care Med. 159:1249-1256.
51. Iregui, M., S. Ward, G. Sherman, V. J. Fraser, and M. H. Kollef. 2002. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest 122:262-268.
52. Jacobs, R. F. 1991. Nosocomial pneumonia in children. Infection 19:64-72.
53. Jantausch, B. A., J. Deville, S. Adler, M. R. Morfin, P. Lopez, B. Edge-Padbury, S. Naberhuis-Stehouwer, and J. B. Bruss. 2003. Linezolid for the treatment of children with bacteremia or nosocomial pneumonia caused by resistant gram-positive bacterial pathogens. Pediatr. Infect. Dis. J. 22:S164-S171.
54. Johnson, K. L., P. A. Kearney, S. B. Johnson, J. B. Niblett, N. L. MacMillan, and R. E. McClain. 1994. Closed versus open endotracheal suctioning: costs and physiologic consequences. Crit. Care Med. 22:658-666.
55. Kelleghan, S. I., C. Salemi, S. Padilla, M. McCord, G. Mermilliod, T. Canola, and L. Becker. 1993. An effective continuous quality improvement approach to the prevention of ventilator-associated pneumonia. Am. J. Infect. Control 21:322-330.
56. Kennedy, A. M., A. M. Elward, and V. J. Fraser. 2004. Survey of knowledge, beliefs, and practices of neonatal intensive care unit healthcare workers regarding nosocomial infections, central venous catheter care, and hand hygiene. Infect. Control Hosp. Epidemiol. 25:747-752.
57. Kerem, E., I. Yatsiv, and K. J. Goitein. 1990. Effect of endotracheal suctioning on arterial blood gases in children. Intensive Care Med. 16:95-99.
58. Kohler, P. F., and R. S. Farr. 1966. Elevation of cord over maternal IgG immunoglobulin: evidence for an active placental IgG transport. Nature 210:1070-1071.
59. Kollef, M. H., G. Sherman, S. Ward, and V. J. Fraser. 1999. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 115:462-474.
60. Labenne, M., C. Poyart, C. Rambaud, B. Goldfarb, B. Pron, P. Jouvet, C. Delamare, G. Sebag, and P. Hubert. 1999. Blind protected specimen brush and bronchoalveolar lavage in ventilated children. Crit. Care Med. 27:2537-2543.
61. Liberati, A., R. D'Amico, Pifferi, V. Torri, and L. Brazzi. 2004. Antibiotic prophylaxis to reduce respiratory infections and mortality in adults receiving intensive care. Cochrane Database Syst. Rev. 2004(1):CD000022.
62. Lopriore, E., D. G. Markhorst, and R. J. Gemke. 2002. Ventilator-associated pneumonia and upper airway colonisation with gram negative bacilli: the role of stress ulcer prophylaxis in children. Intensive Care Med. 28:763-767.
63. Luna, C. M., P. Vujacich, M. S. Niederman, C. Vay, C. Gherardi, J. Matera, and E. C. Jolley. 1997. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest 111:676-685.
64. Meissner, H. C., T. Tonwsend, W. Wenman, S. L. Kaplan, M. R. Morfin, B. Edge-Padbury, S. Naberhuis-Stehouwer, and J. B. Bruss. 2003. Hematologic effects of linezolid in young children. Pediatr. Infect. Dis. J. 22:S186-S192.
65. Morar, P., Z. Makura, A. Jones, P. Baines, A. Selby, J. Hughes, and R. van Saene. 2000. Topical antibiotics on tracheostoma prevents exogenous colonization and infection of lower airways in children. Chest 117:513-518.
66. Morrow, B., and A. Argent. 2001. Risks and complications of nonbronchoscopic bronchoalveolar lavage in a pediatric intensive care unit. Pediatr. Pulmonol. 32:378-384.
67. Munro, C. L., and M. J. Grap. 2004. Oral health and care in the intensive care unit: state of the science. Am. J. Crit. Care 13:25-34.
68. National Nosocomial Infections Surveillance System. 2004. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1992 through June 2004, issued October 2004. Am. J. Infect. Control 32:470-485.
69. Ng, S. P., J. M. Gomez, S. H. Lim, and N. K. Ho. 1998. Reduction of nosocomial infection in a neonatal intensive care unit (NICU). Singapore Med. J. 39:319-323.
70. Papazian, L., F. Bregeon, X. Thirion, R. Gregoire, P. Saux, J. P. Denis, G. Perin, J. Charrel, J. F. Dumon, J. P. Affray, and F. Gouin. 1996. Effect of ventilator-associated pneumonia on mortality and morbidity. Am. J. Respir. Crit. Care Med. 154:91-97.
71. Perkins, G. D., S. Chatterjee, S. Giles, D. F. McAuley, S. Quinton, D. R. Thickett, and F. Gao. 2005. Safety and tolerability of nonbronchoscopic lavage in ARDS. Chest 127:1358-1363.
72. Pessoa-Silva, C. L., R. Richtmann, R. Calil, R. M. Santos, M. L. Costa, A. C. Frota, and S. B. Wey. 2004. Healthcare-associated infections among neonates in Brazil. Infect. Control Hosp. Epidemiol. 25:772-777.
73. Pineda, L. A., R. G. Saliba, and A. A. El Solh. 2006. Effect of oral decontamination with chlorhexidine on the incidence of nosocomial pneumonia: a meta-analysis. Crit. Care 10:R35.
74. Pittet, D. 2000. Improving compliance with hand hygiene in hospitals. Infect. Control Hosp. Epidemiol. 21:381-386.
75. Pittet, D., S. Dharan, S. Touveneau, V. Sauvan, and T. V. Perneger. 1999. Bacterial contamination of the hands of hospital staff during routine patient care. Arch. Intern. Med. 159:821-826.
76. Prober, C. G., P. D. Walson, J. Jones, and the Committee on Infectious Diseases and Committee on Drugs. 2000. Technical report: precautions regarding the use of aerosolized antibiotics. Pediatrics 106:e89.
77. Raymond, J., Y. Aujard, and the European Study Group. 2000. Nosocomial infections in pediatric patients: a European, multicenter prospective study. Infect. Control Hosp. Epidemiol. 21:260-263.
78. Richards, M. J., J. R. Edwards, D. H. Culver, R. P. Gaynes, and the National Nosocomial Infections Surveillance System. 1999. Nosocomial infections in pediatric intensive care units in the United States. Pediatrics 103:e39.
79. Riedler, J., J. Grigg, and C. F. Robertson. 1995. Role of bronchoalveolar lavage in children with lung disease. Eur. Respir. J. 8:1725-1730.
80. Rouby, J. J., E. M. De Lassale, P. Poete, M. H. Nicolas, L. Bodin, V. Jarlier, Y. Le Charpentier, J. Grosset, and P. Viars. 1992. Nosocomial bronchopneumonia in the critically ill. Histologic and bacteriologic aspects. Am. Rev. Respir. Dis. 146:1059-1066.
81. Ruza, F., F. Alvarado, R. Herruzo, M. A. Delgado, S. Garcia, P. Dorao, and F. Goded. 1998. Prevention of nosocomial infection in a pediatric intensive care unit (PICU) through the use of selective digestive decontamination. Eur. J. Epidemiol. 14:719-727.
82. Saiman, L., J. Goldfarb, S. A. Kaplan, K. Wible, B. Edge-Padbury, S. Naberhuis-Stehouwer, and J. B. Bruss. 2003. Safety and tolerability of linezolid in children. Pediatr. Infect. Dis. J. 22:S193-S200.
83. Shlaes, D. M., D. N. Gerding, J. F. John, Jr., W. A. Craig, D. L. Bornstein, R. A. Duncan, M. R. Eckman, W. E. Farrer, W. H. Greene, V. Lorian, S. Levy, J. E. McGowan, Jr., S. M. Paul, J. Ruskin, F. C. Tenover, and C. Watanakunakorn. 1997. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Clin. Infect. Dis. 25:584-599.
84. Shorr, A. F., J. H. Sherner, W. L. Jackson, and M. H. Kollef. 2005. Invasive approaches to the diagnosis of ventilator-associated pneumonia: a meta-analysis. Crit. Care Med. 33:46-53.
85. Singh, N., P. Rogers, C. W. Atwood, M. M. Wagener, and V. L. Yu. 2000. Short-course empirical antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit: a proposed solution for indiscriminate antibiotic prescription. Am. J. Respir. Crit. Care Med. 162:505-511.
86. Sole, M. L., F. E. Poalillo, J. F. Byers, and J. E. Ludy. 2002. Bacterial growth in secretions and on suctioning equipment of orally intubated patients: a pilot study. Am. J. Crit. Care 11:141-149.
87. Squire, E. N., Jr., H. M. Reich, G. B. Merenstein, B. E. Favara, and J. K. Todd. 1982. Criteria for the discontinuation of antibiotic therapy during presumptive treatment of suspected neonatal infection. Pediatr. Infect. Dis. 1:85-90.
88. Stover, B. H., S. T. Shulman, D. F. Bratcher, M. T. Brady, G. L. Levine, W. R. Jarvis, and the Pediatric Prevention Network. 2001. Nosocomial infection rates in US children's hospitals' neonatal and pediatric intensive care units. Am. J. Infect. Control 29:152-157.
89. Tablan, O. C., L. J. Anderson, R. Besser, C. Bridges, R. Hajjeh, CDC, and Healthcare Infection Control Practices Advisory Committee. 2004. Guidelines for preventing health-care-associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. Morb. Mortal. Wkly. Rep. Recomm. Rep. 53:1-36.
90. Tejerina, E., F. Frutos-Vivar, M. I. Restrepo, A. Anzueto, F. Abroug, F. Palizas, M. Gonzalez, G. D'Empaire, C. Apezteguia, A. Esteban, et al. 2006. Incidence, risk factors, and outcome of ventilator-associated pneumonia. J. Crit. Care 21:56-65.
91. Toltzis, P., C. Hoyen, S. Spinner-Block, A. E. Salvator, and L. B. Rice. 1999. Factors that predict preexisting colonization with antibiotic-resistant gram-negative bacilli in patients admitted to a pediatric intensive care unit. Pediatrics 103:719-723.
92. Toltzis, P., and J. L. Blumer. 2001. Nosocomial acquisition and transmission of antibiotic-resistant gram-negative organisms in the pediatric intensive care unit. Pediatr. Infect. Dis. J. 20:612-618.
93. Toltzis, P., T. Yamashita, L. Vilt, and J. L. Blumer. 1997. Colonization with antibiotic-resistant gram-negative organisms in a pediatric intensive care unit. Crit. Care Med. 25:538-544.
94. Torres, A., R. Aznar, J. M. Gatell, P. Jimenez, J. Gonzalez, A. Ferrer, R. Celis, and R. Rodriguez-Roisin. 1990. Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patients. Am. Rev. Respir. Dis. 142:523-528.
95. Trouillet, J. L., J. Chastre, A. Vuagnat, M. L. Joly-Guillou, D. Combaux, M. C. Dombret, and C. Gibert. 1998. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am. J. Respir. Crit. Care Med. 157:531-539.
96. van Houten, M. A., M. Laseur, and J. L. Kimpen. 1998. Shift in antibiotic prescribing patterns in relation to antibiotic expenditure in paediatrics. Eur. J. Pediatr. 157:479-481.
97. van Nieuwenhoven, C. A., E. Buskens, F. H. van Tiel, and M. J. Bonten. 2001. Relationship between methodological trial quality and the effects of selective digestive decontamination on pneumonia and mortality in critically ill patients. JAMA 286:335-340.
98. Webber, S., A. R. Wilkinson, D. Lindsell, P. L. Hope, S. R. Dobson, and D. Isaacs. 1990. Neonatal pneumonia. Arch. Dis. Child. 65:207-211.
99. Won, S. P., H. C. Chou, W. S. Hsieh, C. Y. Chen, S. M. Huang, K. I. Tsou, and P. N. Tsao. 2004. Handwashing program for the prevention of nosocomial infections in a neonatal intensive care unit. Infect. Control Hosp. Epidemiol. 25:742-746.
100. Wunderink, R. G., J. Rello, S. K. Cammarata, R. V. Croos-Dabrera, and M. H. Kollef. 2003. Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia. Chest 124:1789-1797.
101. Yildizdas, D., H. Yapicioglu, and H. L. Yilmaz. 2002. Occurrence of ventilator-associated pneumonia in mechanically ventilated pediatric intensive care patients during stress ulcer prophylaxis with sucralfate, ranitidine, and omeprazole. J. Crit. Care 17:240-245.